| Autor: |
Valencia López, María José, Meineke, Anna, Stephan, Brigitte, Rustenbach, Stephan Jeff, Kis, Anne, Thaçi, Diamant, Mrowietz, Ulrich, Reich, Kristian, Staubach‐Renz, Petra, von Kiedrowski, Ralph, Bogena, Henriette, Augustin, Matthias |
| Předmět: |
|
| Zdroj: |
Journal of the European Academy of Dermatology & Venereology; Jul2023, Vol. 37 Issue 7, pe831-e833, 3p |
| Abstrakt: |
Interestingly, most patients using systemic treatment stated that they did not interrupt their systemic treatment due to the SARS-CoV-2 vaccination ( I n i = 2788 out of 3713, 75.1%), whereas 23.7% ( I n i = 879) reported a temporary interruption, occurring between 14 and 90 days before (63.0%) and after (67.2%) the SARS-CoV-2 vaccination. Among the vaccinated patients, 88% ( I n i = 4084) received at least three vaccine doses, 10.7% ( I n i = 495) two doses and 0.9% ( I n i = 41) a single dose (Figure 1). Among minor, reported AE was the exacerbation of psoriasis (11 affected patients, 0.4%): six patients after the first dose, nine patients after the second dose and eight patients after the third dose. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text